SIGMAR1 and HIV-associated neurocognitive disorder: While many functions of Sig1R pharmacology in HIV studies are still unknown, treatment with Sig1R antagonist BD1047 has been proposed as a plausible therapeutic measure in slowing the progression of HAND in HIV-infected cocaine users.